Novella Carannante
Overview
Explore the profile of Novella Carannante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
550
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meini S, Bracalente I, Sbrana F, Ripoli A, Andreini R, Galli R, et al.
Am J Med
. 2024 Nov;
138(3):504-512.
PMID: 39542076
Background: Coagulation plays a crucial role in innate immune response to invasive infections. Coagulative biomarkers might predict clinical outcomes differently, depending on etiology. Methods: A retrospective study was conducted during...
2.
Russo A, Gulli S, DAvino A, Borrazzo C, Carannante N, Cogliati Dezza F, et al.
Int J Antimicrob Agents
. 2024 May;
64(1):107190.
PMID: 38697579
Background: Severe infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) have been reported increasingly over the past few years. Many in-vivo and in-vitro studies have suggested a possible role of intravenous...
3.
Tascini C, Giuliano S, Attanasio V, Segreti L, Ripoli A, Sbrana F, et al.
Antibiotics (Basel)
. 2023 Jun;
12(6).
PMID: 37370320
(1) Background: Infections are among the most frequent and life-threatening complications of cardiovascular implantable electronic device (CIED) implantation. The aim of this study is to compare the outcome and safety...
4.
Mascolo A, Carannante N, Mauro G, Sarno M, Costanzo M, Licciardi F, et al.
J Infect Public Health
. 2023 Jan;
16(3):376-383.
PMID: 36702012
The ESCMID-EUCIC guideline on decolonization of multidrug-resistant Gram-negative bacteria carriers does not recommend routine decolonization and highlights the necessity of well-powered and designed randomized clinical trials. Based on this limited...
5.
Perrella A, Fortinguerra F, Pierantozzi A, Capoluongo N, Carannante N, Lo Vecchio A, et al.
Antibiotics (Basel)
. 2023 Jan;
12(1).
PMID: 36671369
Antimicrobial resistance (AMR) represents a major issue in healthcare being correlated to global inappropriate use of antibiotics. The aim of this study was to compare the data on hospital antibiotic...
6.
Polistina G, Di Somma C, Flora M, Maraolo A, Carannante N, Langella G, et al.
Monaldi Arch Chest Dis
. 2022 Sep;
93(2).
PMID: 36062992
The World Health Organization declared the Coronavirus Diseases 2019 (COVID-19) outbreak a global pandemic on March 11, 2020. COVID-19 had an impact on over 500 million people worldwide. According to...
7.
Carannante N, Tiberio C, Bellopede R, Liguori M, Di Martino F, Maturo N, et al.
Pathogens
. 2022 Aug;
11(8).
PMID: 36014990
As of 15 June, there have been, globally, a total of 2103 laboratory-confirmed cases and one probable case of Monkeypox, including one death. We report two cases of vesicular infectious...
8.
Bassetti M, Vena A, Giacobbe D, Trucchi C, Ansaldi F, Antonelli M, et al.
Infect Dis Ther
. 2022 Feb;
11(2):827-840.
PMID: 35182353
Introduction: Intra-abdominal infections represent the second most frequently acquired infection in the intensive care unit (ICU), with mortality rates ranging from 20% to 50%. Candida spp. may be responsible for...
9.
Di Micco P, Camporese G, Cardillo G, Lodigiani C, Carannante N, Annunziata A, et al.
Medicina (Kaunas)
. 2021 Oct;
57(10).
PMID: 34684034
SARS-CoV-2 induced a pandemic that is reported to have started in Asia and was then extended to other countries in the world. Main clinical aspects of this viral infection have...
10.
Annunziata A, Coppola A, Andreozzi P, Lanza M, Simioli F, Carannante N, et al.
J Multidiscip Healthc
. 2021 Oct;
14:2857-2861.
PMID: 34675533
Gastrointestinal involvement in SARS-CoV-2 disease (COVID-19) can occur and evolve fatally. Reports are emerging that SARS-CoV-2 virus attacks the pancreatic cells, causing the boost of amylase and lipase serum activity...